David M. Polen
Polen Capital Management
Polen Capital Management Boston Scientific Corp stake
total: 588
Polen Capital Management BSX trades
- Total transactions:
- 4
- New positions:
- 1
- Reduced:
- 3
- Held since:
- 2025 Q3
- Held for:
- 4 quarters
- Latest activity:
- 2026 Q2
According to 2026 Q2 report, Polen Capital Management holds 4,750 Boston Scientific Corp (BSX) shares with a market value of roughly $202.73K accounting for 0.00% of the overall portfolio. To date, the estimated cost basis is nearly $97.63 for "buy" trades and estimated average "sell" price is $69.89. Polen Capital Management first purchased BSX in 2025 Q3, initially acquiring about 5.60M shares. Since the initial investment in Boston Scientific Corp (BSX), Polen Capital Management has made 3 more transactions.
When did Polen Capital Management buy Boston Scientific Corp (BSX)?
Polen Capital Management first invested in Boston Scientific Corp (BSX) in 2025 Q3 at the reported quarter-end price of $97.63 per share.
What's the cost basis of Polen Capital Management's BSX stake?
The estimated cost basis for Boston Scientific Corp (BSX) stake is around $97.63 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $97.63
- Weighted AVG sell price:
- $69.89
Polen Capital Management's historical trades in Boston Scientific Corp
4 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q2
|
0.00%
|
4,750
|
$42.68
|
$202,733
|
-99.18% (-574,989)
|
-0.17%
|
|
2026 Q1
|
0.25%
|
579,739
|
$62.75
|
$36,378,606
|
-85.58% (-3,439,813)
|
-0.92%
|
|
2025 Q4
|
1.64%
|
4,019,552
|
$95.35
|
$383,264,286
|
-28.20% (-1,578,734)
|
-0.49%
|
|
2025 Q3
|
1.77%
|
5,598,286
|
$97.63
|
$546,560,636
|
new
|
+1.77%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.